1. 1Schering-Plough. (2008) IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs. Simvastatin. Available at: http://clinicaltrials.gov/ct2/show/NCT00202878.
2. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial;Goff;The American Journal of Cardiology,2007
3. 3ASCEND Website (2008) Available at: http://www.ctsu.ox.ac.uk/ascend/further_pro.htm.
4. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention);Origin;American Heart Journal,2008
5. 5Merck & Co. HPS2-THRIVE: Treatment of High density lipoprotein to Reduce the Incidence of Vascular Events. (2008) Available at: http://www.controlled-trials.com/cctspringview2/mrct/showTrial.html?mrid=258393&srch=.